Review: taking Toradol and Hydroxyzine pamoate together


Summary

Drug interactions are reported among people who take Toradol and Hydroxyzine pamoate together. This review analyzes the effectiveness and drug interactions between Toradol and Hydroxyzine pamoate. It is created by eHealthMe based on reports of 118 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Toradol and Hydroxyzine pamoate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Toradol

Toradol has active ingredients of ketorolac tromethamine. It is often used in pain. (latest outcomes from Toradol 3,930 users)

Hydroxyzine Pamoate

Hydroxyzine pamoate has active ingredients of hydroxyzine pamoate. It is often used in stress and anxiety. (latest outcomes from Hydroxyzine pamoate 988 users)

On Jul, 22, 2016

118 people who take Toradol, Hydroxyzine Pamoate are studied.


Number of reports submitted per year:

Toradol and Hydroxyzine pamoate drug interactions.

Drug effectiveness over time:

Toradol:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Hydroxyzine Pamoate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Toradol:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 1 people)
Hydroxyzine Pamoate:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Toradol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Hydroxyzine Pamoate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • blood chloride increased
  • haematocrit decreased
  • haemoglobin decreased
  • maternal exposure during pregnancy
  • red blood cell count decreased
  • red cell distribution width increased
  • reticulocyte count increased
  • status migrainosus
  • bronchitis chronic
  • chronic asthma
1 - 2 years:
  • bronchitis chronic
  • chronic asthma
  • copd
  • depression
  • dizziness (excl vertigo)
  • eye inflammation
  • eyes - sensitive to light
  • headache - mixed tension migraine
  • leukocytosis
  • rhinitis allergic
not specified:
  • anxiety
  • pain
  • dysphagia
  • fatigue
  • anhedonia
  • weight decreased
  • bone disorder
  • osteoarthritis
  • chest pain
  • osteomyelitis

Most common drug interactions by gender *:

female:
  • anxiety
  • pain
  • bone disorder
  • osteoarthritis
  • weight decreased
  • dysphagia
  • osteomyelitis
  • depression
  • anhedonia
  • fatigue
male:
  • cardiac failure congestive
  • sleep apnoea syndrome
  • autonomic neuropathy
  • basal cell carcinoma
  • cardioactive drug level increased
  • carotidynia
  • coronary artery disease
  • dysphagia
  • fatigue
  • glucose tolerance impaired

Most common drug interactions by age *:

10-19:
  • status migrainosus
  • blood chloride increased
  • haematocrit decreased
  • haemoglobin decreased
  • maternal exposure during pregnancy
  • red blood cell count decreased
  • red cell distribution width increased
  • reticulocyte count increased
  • cholecystitis
  • cholecystitis acute
20-29:
  • pyrexia
  • deep vein thrombosis
  • dyspnoea
  • fatigue
  • injection site abscess
  • injection site infection
  • injection site inflammation
  • nausea
  • oedema peripheral
  • pain in extremity
30-39:
  • anxiety
  • pain
  • pulmonary embolism
  • cholecystitis chronic
  • pancreatitis
  • cerebrovascular accident
  • diabetes mellitus
  • cholelithiasis
  • asthenia
  • back pain
40-49:
  • tricuspid valve incompetence
  • mitral valve incompetence
  • nausea
  • dyspnoea exertional
  • muscle spasms
  • oedema lower limb
  • pain in limb
  • cardiac arrest
  • dry mouth
  • fatigue
50-59:
  • fatigue
  • chest pain
  • pain
  • cardiac failure congestive
  • depression
  • dyspnoea
  • asthenia
  • dizziness
  • dysphagia
  • anxiety
60+:
  • anxiety
  • pain
  • osteoarthritis
  • anhedonia
  • bone disorder
  • osteomyelitis
  • weight decreased
  • dysphagia
  • osteonecrosis of jaw
  • pain in extremity

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Toradol and Hydroxyzine pamoate?

Can you answer these questions?

More questions for: Toradol, Hydroxyzine pamoate

You may be interested in these reviews

More reviews for: Toradol, Hydroxyzine pamoate

On eHealthMe, Toradol (ketorolac tromethamine) is often used to treat pain. Hydroxyzine pamoate (hydroxyzine pamoate) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.